companiesSEC EDGAR

BridgeBio Pharma, Inc.

Reading list ↗
Thematic photograph: Capitol at Dusk 2.jpg
Thematic photoMartin FalbisonerCC BY-SA 3.0Resized, encoded as WebP; displayed with responsive cropping under the original licence

SEC EDGAR published this disclosure on 2026-08-20. Read the original document for its full text and supporting detail.

Open the original document at SEC EDGAR ↗
accession0001470831-26-000848
acquired disposedD
codeS
direct or indirectI
form4
is derivativefalse
issuer nameBridgeBio Pharma, Inc.
labelOpen market sale
Source record & verificationDates, provenance and technical details

Context

links are based on the recorded entity type
FieldRecorded value
EntityBridgeBio Pharma, Inc.
SourceSEC EDGAR ↗
News sectioncompanies
Source identifier0001470831-26-000848
Source-linked related entitieskumar-neil-1742485 · person
Event ID#895505
Recorded payloadStructured source data

Recorded payload

JSON payload as stored after parsing
{
  "accession": "0001470831-26-000848",
  "acquired_disposed": "D",
  "code": "S",
  "direct_or_indirect": "I",
  "form": "4",
  "is_derivative": false,
  "issuer_name": "BridgeBio Pharma, Inc.",
  "label": "Open market sale",
  "person_name": "Kumar Neil",
  "price": 85.65,
  "role": "Director, Chief Executive Officer",
  "security": "Common Stock",
  "shares": 100,
  "shares_owned_after": 505686,
  "source_path": "edgar/data/1743881/0001470831-26-000848.txt",
  "ticker": "BBIO",
  "transaction_date": "2026-08-19",
  "value": 8565
}

Evidence-based analysis

facts, provenance and explicit model coverage
Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.
DimensionStatus / valueMethod or boundary
What happenednot_coveredThe source record has no short title or summary.
Whensource_backed · reported 2026-08-20Occurred 2026-08-19. Source-record timestamps; no timezone or event time is inferred.
Affected entitiesresolved · BridgeBio Pharma, Inc. · 1 relatedCanonical primary entity and stored related_entity_ids only.
Event classificationinsider · insider.sellcanonical event type plus source-provided category; no sentiment or impact is inferred
Entity linkingresolvedCanonical entity resolved during ingestion
Deduplicationappliedunique source event key at ingestion
Source trusthigh · terms allowedSource registry metadata
Sentimentnot_coveredNo sentiment model output is published for this record.
Market reactionnot_coveredRequires licensed quote, candle and volume observations for the affected instrument.
Historical analogsnot_coveredRequires an audited event-cluster corpus and matching methodology.
Impact mechanismnot_coveredNo causal market-impact model is published for this record.
Related risksnot_coveredRisk implications require an audited instrument/entity exposure model.
Instrument linkagenot_coveredNo instrument relation is inferred from an entity event; licensed instrument mapping is required.

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-08-20T00:00:00Z

BridgeBio Pharma, Inc. — recorded event — investment.com